Clinical Trial Update: Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer [NA]

View source ↗

Summary

This clinical trial update notes the withdrawal of a Phase II study evaluating first-line stereotactic body radiotherapy for non-metastatic unresectable pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Pancreatic Tumor | NA | Status: WITHDRAWN